Stock Slips As Atricure Acquires Competitor For $149m

Stock in AtriCure Inc. dropped nearly 11 percent today on news that the West Chester company has agreed to acquire a North Carolina-based competitor, nContact Inc., for up to $149 million. Shares in AtriCure (Nasdaq: ATRC) declined from a previous close of $22.45 to $20 by midday. The stock has ranged from $13.19 to $28.15 over the last 52 weeks. AtriCure is best known for making medical devices to treat atrial fibrillation, a common malady characterized by an irregular and fast heartbeat.

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News